Introduction

Twin-to-Twin Transfusion Syndrome (TTTS) is a severe and potentially life-threatening condition that occurs in monochorionic, diamniotic (MCDA) twin pregnancies ¹. It arises from an imbalance in blood flow between the fetuses due to vascular connections in the placenta, leading to significant complications for both twins ². The aetiology and underlying mechanisms of TTTS are complex and multifactorial, involving placental vascular anatomy, abnormal placental blood flow, and genetic factors ³. Understanding these mechanisms is crucial for managing and preventing TTTS, as early diagnosis and intervention can significantly improve fetal outcomes ⁴.

This article explores the aetiology, pathophysiology, and mechanisms of TTTS in monochorionic pregnancies, focusing on placental vascular abnormalities, hemodynamic changes, and diagnostic and therapeutic strategies ¹.

Monochorionic Pregnancies: Definition and Background

Monochorionic pregnancies occur when twins share a single placenta, as opposed to dichorionic pregnancies, where each fetus has its placenta ¹. These pregnancies are classified into two main categories: monochorionic-diamniotic (MCDA), where each fetus has a separate amniotic sac, and monochorionic-monoamniotic (MCMA), where both fetuses share a single amniotic sac ².

The majority of TTTS cases occur in MCDA pregnancies, as the shared placenta presents a standard circulatory system for both fetuses ³. In such pregnancies, the fetuses are connected through a network of placental vessels, which may include arterio-venous anastomoses ⁴. These abnormal connections can lead to unbalanced blood flow between the two fetuses, with one twin receiving too much blood (the "recipient") and the other twin receiving too little (the "donor"). This imbalance in blood flow causes the characteristic signs and symptoms of TTTS ¹.

Aetiology of TTTS

Placental Vascular Anomalies

The primary aetiology of TTTS lies in the vascular abnormalities within the shared placenta ². These anomalies typically involve the presence of arteriovenous (AV) anastomoses, which are abnormal direct connections between the arterial and venous systems in the placenta ³. These anastomoses allow blood to be transferred between the vessels of the two fetuses, often leading to an unequal distribution of blood supply ⁴.

Several types of placental vascular connections contribute to the development of TTTS ¹:

1. Arterio-venous (AV) Anastomoses: These are the most common form of placental vascular connections in TTTS ². In a typical MCDA pregnancy, the shared placenta contains arteries and veins that carry blood to and from each fetus ³. However, AV anastomoses form when these arteries and veins directly connect, bypassing the capillary network ⁴. This abnormality results in an unbalanced blood flow between the fetuses, leading to one twin receiving excessive blood supply (recipient) and the other being deprived (donor) ¹.
2. Arterio-arterial (AA) Anastomoses: In addition to AV anastomoses, arterio-arterial connections can contribute to TTTS ². These connections are less common but can still cause significant hemodynamic disturbances ³. AA anastomoses can exacerbate the imbalance in blood flow, complicating the clinical course of the syndrome ⁴.
3. Venous-venous (VV) Anastomoses: Although rare, VV anastomoses can also contribute to TTTS ¹. These connections link the venous systems of the fetuses ², further contributing to blood redistribution ³. VV anastomoses can create additional pathophysiological challenges in the placental circulation ⁴.

Fetal Hemodynamics and Blood Flow

TTTS arises due to an imbalance in blood flow between the two fetuses, with one twin becoming the recipient and the other the donor ¹. The pathophysiology of TTTS is characterised by two critical hemodynamic changes ²:

1. Recipient Twin: The recipient twin receives excessive blood due to the abnormal blood flow from the donor twin ³. As a result, the recipient becomes hypervolemic, leading to increased blood pressure, polyhydramnios (excess amniotic fluid), and signs of heart failure ⁴. The recipient's cardiovascular system becomes overwhelmed, often leading to hydrops fetalis, a condition characterised by widespread fluid accumulation in fetal tissues ¹.
2. Donor Twin: In contrast, the donor twin is deprived of blood and experiences hypovolemia ². This leads to oligohydramnios (reduced amniotic fluid), growth restriction, and signs of anemia ³. The donor twin may develop severe intrauterine growth restriction (IUGR) and, in extreme cases, can experience fetal demise ⁴.

The imbalance in blood flow between the twins is exacerbated by the unequal placental perfusion ¹, which results in differences in the oxygen and nutrient supply to each fetus ². These differences contribute to the pathophysiology of TTTS ³, with the recipient twin exhibiting signs of hypervolemia and cardiovascular strain ⁴, while the donor twin shows signs of hypovolemia and growth restriction ¹.

Mechanisms of TTTS Development

Several mechanisms underlie the development of TTTS ². These include abnormalities in placental vascularisation, hemodynamic changes, and the influence of maternal and fetal factors ³. Fundamental mechanisms contributing to the development of TTTS include ⁴:

1. Imbalance in Placental Blood Flow

The most fundamental mechanism behind TTTS is the imbalance in placental blood flow between the two fetuses ¹. In a normal pregnancy, blood flow to each fetus is evenly distributed, with each fetus receiving an adequate supply of oxygen and nutrients ². However, in TTTS, abnormal AV anastomoses or other vascular anomalies lead to the shunting of blood from one twin to the other, causing unequal perfusion ³.

The recipient twin's excessive blood flow increases its blood volume and can lead to complications such as heart failure, hydrops, and polyhydramnios ⁴. The donor twin, on the other hand, suffers from a reduced blood supply, leading to anaemia, growth restriction, and oligohydramnios ¹.

1. Hemodynamic Changes and Cardiovascular Strain

As blood flow is redirected from one twin to the other ², the recipient twin experiences increased venous return ³, which may lead to elevated central venous pressure and systemic hypertension ⁴. This increase in blood volume results in polyhydramnios, as the recipient twin produces excessive amniotic fluid ¹. The recipient's cardiovascular system becomes stressed, and heart failure may develop in severe cases ². Additionally, the recipient twin is at risk for hydrops, a condition characterised by the accumulation of fluid in fetal tissues and cavities ³.

On the other hand, the donor twin experiences reduced blood flow ⁴, leading to decreased oxygen and nutrient supply ¹. This leads to intrauterine growth restriction (IUGR), oligohydramnios, and signs of anemia ². The donor twin is also at risk of fetal demise ³, especially if the hemodynamic imbalance persists ⁴.

1. Genetic and Environmental Factors

In addition to placental vascular abnormalities and hemodynamic changes ¹, genetic and environmental factors may play a role in the development of TTTS ². Some studies have suggested that genetic predisposition may contribute to developing abnormal vascular anastomoses in the placenta ³. However, the exact genetic mechanisms remain unclear ⁴.

Environmental factors, such as maternal health conditions (e.g., hypertension or diabetes) ¹, may exacerbate the severity of TTTS ². Additionally, certain placental conditions ³, such as placental insufficiency or abnormal trophoblastic invasion ⁴, may further contribute to the development of TTTS ¹.

Diagnosis of TTTS

Early diagnosis of TTTS is critical to prevent severe fetal outcomes ². Ultrasound is the primary tool used to diagnose TTTS and monitor the condition throughout pregnancy ³. Key diagnostic signs of TTTS include ⁴:

1. Polyhydramnios in the Recipient Twin ¹: The recipient twin is at risk for excessive amniotic fluid accumulation, which can lead to polyhydramnios ². This can be detected through ultrasound measurement of the amniotic fluid index (AFI) or visual assessment ³.
2. Oligohydramnios in the Donor Twin ⁴: The donor twin may experience a reduction in amniotic fluid, leading to oligohydramnios ¹. This can also be detected via ultrasound ².
3. Size Discrepancy Between the Twins ³: There may be significant growth differences between the twins, with the recipient twin exhibiting overgrowth and the donor twin showing intrauterine growth restriction (IUGR) ⁴.
4. Doppler Ultrasound ¹: Doppler ultrasound of the umbilical artery and other placental vessels can help identify abnormal blood flow patterns that suggest TTTS ². Abnormal Doppler findings may include reversed or absent end-diastolic flow in the donor twin and increased velocity in the recipient twin ³.

Risk Factors for TTTS

Certain factors increase the likelihood of developing TTTS in monochorionic pregnancies ⁴. These include ¹:

1. Placental Factors ²: Abnormal placental vascular connections, such as arterio-venous anastomoses, are the most significant risk factors for TTTS ³. Placental structural abnormalities, including unequal placental sharing and abnormal vessel distribution, can also contribute to the development of TTTS ⁴.
2. Discordant Growth Between the Twins ¹: Significant differences in fetal size or growth between the twins may indicate the presence of TTTS ². The donor twin typically exhibits intrauterine growth restriction (IUGR), while the recipient twin may show signs of overgrowth or hydrops ³.
3. Gestational Age and Timing of Diagnosis ⁴: TTTS is most commonly diagnosed in the second trimester, around 16-26 weeks of gestation ¹. Early diagnosis allows for earlier intervention, which improves outcomes ². If TTTS develops later in pregnancy, the prognosis may be less favorable ³.
4. Maternal Factors ⁴: Maternal conditions, such as hypertension, diabetes, and obesity, may increase the risk of developing TTTS ¹. Additionally, maternal age, multiple gestations, and previous pregnancies involving TTTS may also elevate the likelihood of recurrence ².

Prevention and Future Directions

While it is currently impossible to prevent TTTS ¹, early detection through routine ultrasound and Doppler studies is crucial for managing the condition effectively ². Screening for TTTS should be a part of routine care for women carrying monochorionic pregnancies ³, as early diagnosis and intervention can significantly improve the chances of a favourable outcome for both twins ⁴.

Ongoing research focuses on better understanding the genetic and molecular mechanisms contributing to abnormal placental vascularisation and TTTS ¹. Advances in imaging technology ², such as 3D ultrasound and advanced Doppler techniques ³, may allow for earlier and more accurate detection of TTTS ⁴. New therapies, including minimally invasive surgical techniques and pharmacological interventions, are also being explored to improve treatment outcomes ¹.

Conclusion

Twin-to-Twin Transfusion Syndrome (TTTS) is a severe complication of monochorionic pregnancies ² caused by abnormal vascular connections within the shared placenta ³. The imbalance in blood flow between the donor and recipient twins results in significant hemodynamic changes ⁴, leading to a range of complications, including polyhydramnios, growth restriction, and organ failure ¹. The aetiology of TTTS lies primarily in abnormal placental vascular anatomy ², with arteriovenous anastomoses being the most common cause of blood flow imbalance ³.

Timely diagnosis and intervention, mainly through laser surgery ⁴, are vital to improving the prognosis for affected twins ¹. While TTTS remains a challenging condition ², advances in diagnostic techniques and treatment options have improved survival rates for both twins ³. Continued research into the underlying mechanisms of TTTS ⁴, along with improvements in prenatal care ¹, will help to refine treatment approaches further and improve outcomes for affected pregnancies ².

References

1. Aleksandra, Barbachowska., Klaudia, Krzanik., Mikołaj, Baliś., Iwona, Janosz., Piotr, Bodzek., Anita, Olejek. 1. Twin-to-twin transfusion syndrome (TTTS) pathogenesis, diagnostics, classification and treatment options. (2018).
2. D, Khairudin., Asma, Khalil. 2. Monochorionic monoamniotic twin pregnancies.. Best Practice & Research in Clinical Obstetrics & Gynaecology, (2022). doi: 10.1016/j.bpobgyn.2022.08.004
3. Matthew, A., Shanahan., M., W., Bebbington. 3. Monochorionic Twins: TTTS, TAPS, and Selective Fetal Growth Restriction. Clinical Obstetrics and Gynecology, (2023). doi: 10.1097/grf.0000000000000821
4. R., Cruz-Martinez., H., López-Briones., J., Luna-García., M., Martinez-Rodriguez., A., Gamez-Varela., E.L., Chávez-González., R., Villalobos-Gómez. 4. Incidence and survival of MCDA twin pregnancies with TTTS presenting without amniotic fluid discordance due to spontaneous septostomy and treated with fetoscopy.. Ultrasound in Obstetrics & Gynecology, (2021). doi: 10.1002/UOG.23129